Current Description

An issue was discovered in Psyprax before 3.2.2. The file %PROGRAMDATA%Psyprax32PPScreen.ini contains a hash for the lockscreen (aka screensaver) of the application. If that entry is removed, the lockscreen is no longer displayed and the app is no longer locked. All local users are able to modify that file.

View Analysis Description

Analysis Description

An issue was discovered in Psyprax before 3.2.2. The file %PROGRAMDATA%Psyprax32PPScreen.ini contains a hash for the lockscreen (aka screensaver) of the application. If that entry is removed, the lockscreen is no longer displayed and the app is no longer locked. All local users are able to modify that file.

Severity

CVSS 3.x Severity and Metrics:

CVSS 2.0 Severity and Metrics:

References to Advisories, Solutions, and Tools

By selecting these links, you will be leaving NIST webspace. We have provided these links to other web sites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other web sites that are more appropriate for your purpose. NIST does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, NIST does not endorse any commercial products that may be mentioned on these sites. Please address comments about this page to [email protected].

Weakness Enumeration

CWE-ID CWE Name Source
CWE-732 Incorrect Permission Assignment for Critical Resource NIST  

Change History

1 change records found show changes

Initial Analysis 2/08/2021 3:22:33 PM

Action Type Old Value New Value
Added CPE Configuration
OR
     *cpe:2.3:a:psyprax:psyprax:*:*:*:*:*:*:*:* versions up to (excluding) 3.2.2
Added CVSS V2
NIST (AV:L/AC:L/Au:N/C:N/I:P/A:N)
Added CVSS V3.1
NIST AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N
Added CWE
NIST CWE-732
Changed Reference Type
https://www.x41-dsec.de/lab/advisories/x41-2020-002-psyprax No Types Assigned
https://www.x41-dsec.de/lab/advisories/x41-2020-002-psyprax Third Party Advisory